MINERALOCORTICOID RECEPTOR AS A NOVEL THERAPEUTIC TARGET FOR ALCOHOL USE DISORDER? PRELIMINARY EVIDENCE IN RODENTS AND HUMANS

被引：0
|
作者：
Farokhnia, M.
Rentsch, C. T.
Tunstall, B. J.
Gregory-Flores, A.
Tate, J. P.
Koob, G. F.
Fiellin, D. A.
Vendruscolo, L. F.
Justice, A. C.
Leggio, L.
机构：
[1] NIDA, Clin Psychoneuroendocrinol & Neuropsychopharmacol, Baltimore, MD 21224 USA
[2] NIAAA, NIH, Bethesda, MD 20892 USA
来源：
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2020年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
248
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [1] Mineralocorticoid receptor as a novel therapeutic target for alcohol use disorder? Preliminary evidence in rodents and humans
    Rentsch, Christopher T.
    Farokhnia, Mehdi
    Tate, Janet P.
    Tunstall, Brendan J.
    Gregory-Flores, Adriana
    Bryant, Kendall J.
    Koob, George F.
    Vendruscolo, Leandro F.
    Fiellin, David A.
    Leggio, Lorenzo
    Justice, Amy C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 439 - 439
  • [2] The Mineralocorticoid Receptor: An Emerging Pharmacotherapeutic Target for Alcohol Use Disorder?
    Leko, Andras H.
    McGinn, M. Adrienne
    Farokhnia, Mehdi
    ACS CHEMICAL NEUROSCIENCE, 2022, : 1832 - 1834
  • [3] Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents
    Walker, Leigh C.
    Berizzi, Alice E.
    Chen, Nicola A.
    Rueda, Patricia
    Perreau, Victoria M.
    Huckstep, Katherine
    Srisontiyakul, Jirawoot
    Govitrapong, Piyarat
    Jia Xiaojian
    Lindsley, Craig W.
    Jones, Carrie K.
    Riddy, Darren M.
    Christopoulos, Arthur
    Langmead, Christopher J.
    Lawrence, Andrew J.
    BIOLOGICAL PSYCHIATRY, 2020, 88 (12) : 898 - 909
  • [4] Probenecid Reduces Alcohol Drinking in Rodents. Is Pannexin1 a Novel Therapeutic Target for Alcohol Use Disorder?
    Tunstall, Brendan J.
    Lorrai, Irene
    McConnell, Sam A.
    Gazo, Katrina L.
    Zeller, Lia J.
    de Guglielmo, Giordano
    Hoang, Ivy
    Haass-Koffler, Carolina L.
    Repunte-Canonigo, Vez
    Koob, George F.
    Vendruscolo, Leandro F.
    Sanna, Pietro Paolo
    ALCOHOL AND ALCOHOLISM, 2019, 54 (05): : 497 - 502
  • [5] Alcohol metabolism in alcohol use disorder: a potential therapeutic target
    Lehner, Taylor
    Gao, Bin
    Mackowiak, Bryan
    ALCOHOL AND ALCOHOLISM, 2024, 59 (01):
  • [6] Antagonism of the Mineralocorticoid Receptor as a Potential Pharmacotherapy for Alcohol Use Disorder: Convergent Evidence From Rodent and Human Studies
    Farokhnia, Mehdi
    Rentsch, Christopher
    McGinn, Adrienne
    Tunstall, Brendan
    Gregory-Flores, Adriana
    Koob, George
    Fiellin, David
    Vendruscolo, Leandro
    Justice, Amy
    Leggio, Lorenzo
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 152 - 152
  • [7] A novel telehealth platform for alcohol use disorder treatment: preliminary evidence of reductions in drinking
    Mitchell, Mary M.
    Mendelson, John
    Gryczynski, Jan
    Carswell, Steven B.
    Schwartz, Robert P.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2020, 46 (03): : 297 - 303
  • [8] Alcohol Sensitivity as an Endophenotype of Alcohol Use Disorder: Exploring Its Translational Utility between Rodents and Humans
    Parker, Clarissa C.
    Lusk, Ryan
    Saba, Laura M.
    BRAIN SCIENCES, 2020, 10 (10) : 1 - 28
  • [9] Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
    Kana Hamada
    Amy W. Lasek
    Neurotherapeutics, 2020, 17 : 4 - 16
  • [10] Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
    Hamada, Kana
    Lasek, Amy W.
    NEUROTHERAPEUTICS, 2020, 17 (01) : 4 - 16
12345